Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Clin Transl Allergy ; 7: 37, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29075437

RESUMO

A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.

2.
J Nutr Health Aging ; 21(1): 92-104, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27999855

RESUMO

The Strategic Implementation Plan of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) proposed six Action Groups. After almost three years of activity, many achievements have been obtained through commitments or collaborative work of the Action Groups. However, they have often worked in silos and, consequently, synergies between Action Groups have been proposed to strengthen the triple win of the EIP on AHA. The paper presents the methodology and current status of the Task Force on EIP on AHA synergies. Synergies are in line with the Action Groups' new Renovated Action Plan (2016-2018) to ensure that their future objectives are coherent and fully connected. The outcomes and impact of synergies are using the Monitoring and Assessment Framework for the EIP on AHA (MAFEIP). Eight proposals for synergies have been approved by the Task Force: Five cross-cutting synergies which can be used for all current and future synergies as they consider overarching domains (appropriate polypharmacy, citizen empowerment, teaching and coaching on AHA, deployment of synergies to EU regions, Responsible Research and Innovation), and three cross-cutting synergies focussing on current Action Group activities (falls, frailty, integrated care and chronic respiratory diseases).


Assuntos
Envelhecimento , Comportamentos Relacionados com a Saúde , População Branca , Acidentes por Quedas/prevenção & controle , Idoso , Idoso de 80 Anos ou mais , Doença Crônica , Comportamento Cooperativo , Europa (Continente) , Idoso Fragilizado , Humanos , Múltiplas Afecções Crônicas , Inovação Organizacional , Polimedicação , Inquéritos e Questionários
3.
Can Med Assoc J ; 114(1): 27-30, 1976 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-943222

RESUMO

Between 1953 and 1973 the mean incidence of a first breast cancer in northern Alberta was 0.47 per 1000 women. However, in women who had had a first breast cancer the crude incidence of a second primary cancer in the opposite breast was 1.3%. The rate of discovery of a second primary cancer increased after a multidisciplinary approach was instituted at the follow-up clinics. Mammography has proved to be valuable in diagnosis. By this technique 19 (36.5%) of the 52 cancers occurring in the remaining breast were identified when they were clinically unsuspected.


Assuntos
Neoplasias da Mama/diagnóstico por imagem , Mamografia , Metástase Neoplásica/diagnóstico por imagem , Neoplasias Primárias Múltiplas/diagnóstico por imagem , Adulto , Idoso , Alberta , Neoplasias da Mama/epidemiologia , Neoplasias da Mama/genética , Seguimentos , Humanos , Pessoa de Meia-Idade , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA